The report covers a detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Advanced Cell Diagnostics, Janssen Diagnostics, Biocept Inc., ScreenCell, Silicon Biosystems, Aviva Biosciences, Biofluidica Inc., CellTraffix Inc., Fluxion Biosciences Inc., Sysmex Corporation, Epic Sciences Inc., Clearbridge BioMedics Pte Ltd, and Greiner Bio-One GmbH.
Global circulating tumor cell diagnostics market is segmented based on the technology as, CTC Enrichment Methods, CTC Detection Methods, and CTC Analysis. On the basis of application, the global circulating tumor cell diagnostics market is segregated as Cancer Cell Research, EMT Biomarkers Development, and Tumorigenesis Research. Cancer Cell Research is expected to witness notable gains in the forecast years.
Global circulating tumor cell diagnostics market report covers various regions including North America, Europe, Asia Pacific, and Rest of World. The regional circulating tumor cell diagnostics market is further bifurcated for major countries including U.S., Canada, Germany, UK, France, Italy, China, India, Japan, Brazil, South Africa and others.
Browse Full Report: https://www.marketresearchengine.com/circulating-tumor-cell-diagnostics-market
Rising demand for preventive medicines is the key factor for escalating the circulating tumor cell diagnostics market size during the forecast time line. Advancement in multiple tumor markers which can be utilized together with companion diagnostics to monitor and detect various forms of cancer will further boost the industry revenue.
The global circulating tumor cell diagnostics market report covers detailed study with the underlying influencing factors for the variations in the industry growth trends.
Increasing incidences of oncology diseases along with the introduction of novel biotechnological techniques that will enable quantitation and isolation of circulating tumor cells. In addition, other contributing factors for improving industry growth rate include cost savings on multiple treatments, early detetction of disease, patient compliance, and drug safety.
The report scope includes market analysis on regional as well as country level. The report also provides competitive landscape covering company market shares with detailed profiling for major revenue contributing companies.
The report covers:
- Global circulating tumor cell diagnostics market estimates & forecast from 2015 to 2024, with CAGR for 2018-2024.
- Comparative market size analysis for 2017 & 2024, with actual data for 2017, estimates for 2018 and forecast from 2019 to 2024
- Global circulating tumor cell diagnostics market trends, with detailed analysis on consumer trends & manufacturer trends
- Overview on supply analysis covering trends across raw material suppliers, technology providers and distributors
- Key areas of investments identifying market opportunities and challenges in forecast timeframe
- Competitive analysis of the industry players along with the overview on strategic management
- Comprehensive company profiles of the major industry players
Global circulating tumor cell diagnostics market share consists of several players including Advanced Cell Diagnostics, Janssen Diagnostics, Biocept Inc., ScreenCell, Silicon Biosystems, Aviva Biosciences, Biofluidica Inc., CellTraffix Inc., Fluxion Biosciences Inc., Sysmex Corporation, Epic Sciences Inc., Clearbridge BioMedics Pte Ltd, and Greiner Bio-One GmbH.
The Circulating Tumor Cell Diagnostics Market has been segmented as below:
The Circulating Tumor Cell Diagnostics Marketis segmented on the lines ofCirculating Tumor Cell Diagnostics Market, By Technology, Circulating Tumor Cell Diagnostics Market, By Application and Circulating Tumor Cell Diagnostics Market, By Region.
Circulating Tumor Cell Diagnostics Market, By Technologythis market is segmented on the basis ofCTC Enrichment its covers Ex-vivo positive selection, In-vivo positive selection, Negative selection, Microchips&Single spiral micro channel. CTC Detection its covers Immunocytochemical technologies, Molecular (RNA) based technologies, EPISPOT functional in-vitro cell culture, Functional in-vitro cell invasion assay&Xenotransplantation models. And CTC Analysis. Circulating Tumor Cell Diagnostics Market, By Applicationthis market is segmented on the basis ofTumorigenesis research, EMT biomarkers development, Cancer stem cell research and Others. Circulating Tumor Cell Diagnostics Market, By Regionthis market is segmented on the basis ofNorth America, Europe, Asia Pacific and Rest of World.
Reasons to Buy this Report:
- Gain comprehensive insights on the industry trends
- Identify industry opportunities and key growth segments
- Obtain complete market study on the circulating tumor cell diagnostics market
- Facilitate strategy planning for your company based on the industry dynamics
- Evaluate your competitor’s business segments and portfolios
Request Sample Report from here: https://www.marketresearchengine.com/circulating-tumor-cell-diagnostics-market
Table of Contents:
- Research Methodology
- Executive Summary
- Market Overview
4.2.1. Medical need for cancer diagnostics
4.2.2. Potential applications of CTC in cancer management
4.3.1. Rare occurrence of circulating tumor cells
4.3.2. Lack of consistency in detection and enrichment methods
4.4.1. Growing cancer incidence
4.4.2. Rising demand for preventive medicine & companion diagnostics
4.4.3. Development of cluster chip technology
4.5.1. Higher preference of point-of-care testing and absence of POC adaptable CTC
- Circulating Tumor Cell Diagnostics Market, By Technology
- Circulating Tumor Cell Diagnostics Market, By Application
- Competitive Landscape
- Company Profile
8.1. Advanced Cell Diagnostics
8.1.1. Company Overview
8.1.2. Product/Service Landscape
8.1.3. Financial Overview
8.1.4. Recent Developments
8.2. Janssen Diagnostics
8.2.1. Company Overview
8.2.2. Product/Service Landscape
8.2.3. Financial Overview
8.2.4. Recent Developments
8.3. Biocept Inc.
8.3.1. Company Overview
8.3.2. Product/Service Landscape
8.3.3. Financial Overview
8.3.4. Recent Developments
8.4. ScreenCell, Silicon Biosystems
8.4.1. Company Overview
8.4.2. Product/Service Landscape
8.4.3. Financial Overview
8.4.4. Recent Developments
8.5. Aviva Biosciences
8.5.1. Company Overview
8.5.2. Product/Service Landscape
8.5.3. Financial Overview
8.5.4. Recent Developments
8.6. Biofluidica Inc.
8.6.1. Company Overview
8.6.2. Product/Service Landscape
8.6.3. Financial Overview
8.6.4. Recent Developments
8.7. CellTraffix Inc.
8.7.1. Company Overview
8.7.2. Product/Service Landscape
8.7.3. Financial Overview
8.7.4. Recent Developments
8.8. Fluxion Biosciences Inc.
8.8.1. Company Overview
8.8.2. Product/Service Landscape
8.8.3. Financial Overview
8.8.4. Recent Developments
8.9. Sysmex Corporation
8.9.1. Company Overview
8.9.2. Product/Service Landscape
8.9.3. Financial Overview
8.9.4. Recent Developments
8.10. Epic Sciences Inc.
8.10.1. Company Overview
8.10.2. Product/Service Landscape
8.10.3. Financial Overview
8.10.4. Recent Developments
8.11. Clearbridge BioMedics Pte Ltd
8.11.1. Company Overview
8.11.2. Product/Service Landscape
8.11.3. Financial Overview
8.11.4. Recent Developments
8.12. Greiner Bio-One GmbH
8.12.1. Company Overview
8.12.2. Product/Service Landscape
8.12.3. Financial Overview
8.12.4. Recent Developments
Other Related Market News:
Market Research Engine is a global market research and consulting organization. We provide market intelligence in emerging, niche technologies and markets. Our market analysis powered by rigorous methodology and quality metrics provide information and forecasts across emerging markets, emerging technologies and emerging business models. Our deep focus on industry verticals and country reports help our clients to identify opportunities and develop business strategies.
Company Name: Market Research Engine
Contact Person: John Bay
Country: United States